Literature DB >> 25838133

Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program.

Teena Chopra1, Anupama Neelakanta2, Carolyn Dombecki2, Reda A Awali2, Sarit Sharma2, Keith S Kaye2, Paru Patel2.   

Abstract

BACKGROUND: Both Clostridium [corrected] difficile infection (CDI) rates in hospitals and interest in reducing 30-day readmission rates have increased dramatically in the United States. The objective of this study was to characterize the burden of CDI on 30-day hospital readmissions at a tertiary care health-system.
METHODS: A patient discharge database was used to identify patients with a CDI diagnosis (ICD-9 code 008.45) during their stay in 2012. Patients were classified as index admissions (CDI discharges) or 30-day readmissions (CDI readmissions). Readmission rates, length of stay (LOS), and time to readmission were assessed among CDI readmissions.
RESULTS: Among discharges from the health system (n = 51,353), 615 were diagnosed with CDI (1%). Thirty-day readmissions were more common among CDI discharges (30.1%) than non-CDI discharges (14.4%). Average LOS for CDI readmissions was 5-6 days longer than non-CDI readmissions. Time to readmission was shorter among CDI discharges diagnosed on admission than CDI discharges diagnosed later during their hospital stay (median, 7 days).
CONCLUSION: Reductions in hospital-onset CDI and readmission of patients with an index CDI can provide tremendous cost savings to hospitals. This calls for better infection control and antibiotic stewardship measures toward CDI management in the hospital and as patients transition to the next level of care.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  30-day readmissions; Centers for Medicare and Medicaid Services; Clostridium difficile

Mesh:

Substances:

Year:  2015        PMID: 25838133     DOI: 10.1016/j.ajic.2014.11.004

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  13 in total

1.  Vital Signs Are Still Vital: Instability on Discharge and the Risk of Post-Discharge Adverse Outcomes.

Authors:  Oanh Kieu Nguyen; Anil N Makam; Christopher Clark; Song Zhang; Bin Xie; Ferdinand Velasco; Ruben Amarasingham; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2016-08-08       Impact factor: 5.128

2.  Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative.

Authors:  James B Wetmore; David T Gilbertson; Jiannong Liu; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-22       Impact factor: 8.237

3.  Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study.

Authors:  Bojana Milenković; Vesna Šuljagić; Aneta Perić; Viktorija Dragojević-Simić; Olivera Tarabar; Milomir Milanović; Vesna Putić; Diana Tomić; Branislava Miljković; Sandra Vezmar Kovačević
Journal:  Eur J Hosp Pharm       Date:  2021-02-12

4.  Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.

Authors:  Vimalanand S Prabhu; Oliver A Cornely; Yoav Golan; Erik R Dubberke; Sebastian M Heimann; Mary E Hanson; Jane Liao; Alison Pedley; Mary Beth Dorr; Stephen Marcella
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

5.  Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization.

Authors:  Elizabeth Scaria; W Ryan Powell; Jen Birstler; Oguzhan Alagoz; Daniel Shirley; Amy J H Kind; Nasia Safdar
Journal:  BMC Infect Dis       Date:  2020-10-16       Impact factor: 3.090

6.  A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany.

Authors:  Maureen Watt; Charles McCrea; Sukhvinder Johal; John Posnett; Jameel Nazir
Journal:  Infection       Date:  2016-04-09       Impact factor: 3.553

7.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

8.  Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study.

Authors:  Vesna Šuljagić; Bojana Milenković; Aneta Perić; Dragutin Jovanović; Vesna Begović-Kuprešanin; Srđan Starčević; Aleksandar Tomić; Sandra Vezmar Kovačević; Viktorija Dragojević-Simić
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

9.  Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.

Authors:  Anna K Barker; Elizabeth Scaria; Nasia Safdar; Oguzhan Alagoz
Journal:  JAMA Netw Open       Date:  2020-08-03

10.  Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Authors:  Jason P Burnham; Jennie H Kwon; Margaret A Olsen; Hilary M Babcock; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-17       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.